Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Business Economics (Cleveland, Ohio)|August 25, 2020
A strong dollar: help or harm?David Dollar, Nathan Sheets
Cancer|May 13, 2009
Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer researchReshma Jagsi, Nathan Sheets, Aleksandra Jankovic, et al.
Cancer|June 10, 2009
Under-representation of women in high-impact published clinical cancer researchReshma Jagsi, Amy R Motomura, Sudha Amarnath, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|November 21, 2023
NTCP modelling of xerostomia after radiotherapy for oropharyngeal cancer using the PRO-CTCAE and CTCAE scoring systems at different time-points post-RTAthanasios Tzikas, Eleftherios Lavdas, Dimitrios Kehagias, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2017
Dosimetric Predictors of Patient-Reported Xerostomia and Dysphagia With Deintensified Chemoradiation Therapy for HPV-Associated Oropharyngeal Squamous Cell CarcinomaBhishamjit S Chera, David Fried, Alex Price, et al.
Advances in Radiation Oncology|September 11, 2018
Preservation of swallowing function with de-intensified chemoradiation therapy for HPV-associated oropharyngeal squamous cell carcinomaGreg D Judy, Rebecca Green, Shannon L Aumer, et al.
International Journal of Radiation Oncology, Biology, Physics|November 20, 2015
Phase 2 Trial of De-intensified Chemoradiation Therapy for Favorable-Risk Human Papillomavirus-Associated Oropharyngeal Squamous Cell CarcinomaBhishamjit S Chera, Robert J Amdur, Joel Tepper, et al.
Cancer|March 27, 2018
Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinomaBhishamjit S Chera, Robert J Amdur, Joel E Tepper, et al.
International Journal of Radiation Oncology, Biology, Physics|November 6, 2018
Quality of Life for Patients With Favorable-Risk HPV-Associated Oropharyngeal Cancer After De-intensified ChemoradiotherapyKevin A Pearlstein, Kyle Wang, Robert J Amdur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2020
Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal CancerBhishamjit S Chera, Sunil Kumar, Colette Shen, et al.
Pageof 2